Cyclin-Dependent Kinase Inhibitor p19
An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.
Also Known As:
CDKN2D Protein; Cyclin-Dependent Kinase Inhibitor 2D; INK4D Protein; p19INK4D Protein; Cyclin Dependent Kinase Inhibitor 2D; Cyclin Dependent Kinase Inhibitor p19
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Cao, Yanan:
1 article
(07/2015)
|
2. | Cheng, Yulong:
1 article
(07/2015)
|
3. | Gu, Weiqiong:
1 article
(07/2015)
|
4. | Jiang, Xiuli:
1 article
(07/2015)
|
5. | Ning, Guang:
1 article
(07/2015)
|
6. | Shan, Aijing:
1 article
(07/2015)
|
7. | Su, Yutong:
1 article
(07/2015)
|
8. | Wang, Weiqing:
1 article
(07/2015)
|
9. | Bartek, J:
1 article
(08/2000)
|
10. | Bartkova, J:
1 article
(08/2000)
|
Related Diseases
Related Drugs and Biologics